Published in Immunogenetics on January 01, 1999
Dynamic expression of multiple scavenger receptor cysteine-rich genes in coelomocytes of the purple sea urchin. Proc Natl Acad Sci U S A (2000) 1.24
Extraordinary diversity among members of the large gene family, 185/333, from the purple sea urchin, Strongylocentrotus purpuratus. BMC Mol Biol (2007) 0.93
Variant size- and glycoforms of the scavenger receptor cysteine-rich protein gp-340 with differential bacterial aggregation. Glycoconj J (2007) 0.87
Genomic organization and classification of the bovine WC1 genes and expression by peripheral blood gamma delta T cells. BMC Genomics (2009) 0.85
Bovine γδ T cells are a major regulatory T cell subset. J Immunol (2014) 0.84
Increased fetal loss in women with heritable thrombophilia. Lancet (1996) 3.34
Photoreceptor protein from the purple membrane of Halobacterium halobium. Molecular weight and retinal binding site. Biochemistry (1976) 3.08
Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses: novel mRNAs and proteins produced by HTLV type I. J Virol (1992) 2.52
Thrombophilia in pregnancy: a systematic review. Br J Haematol (2006) 2.33
Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT). J Thromb Haemost (2005) 2.13
SP-40,40, a newly identified normal human serum protein found in the SC5b-9 complex of complement and in the immune deposits in glomerulonephritis. J Clin Invest (1988) 1.90
Elements distinct from human immunodeficiency virus type 1 splice sites are responsible for the Rev dependence of env mRNA. J Virol (1994) 1.88
Oral anticoagulation and hemorrhagic complications in an elderly population with atrial fibrillation. Arch Intern Med (2001) 1.82
Molecular cloning of a member of the gene family that encodes pMGA, a hemagglutinin of Mycoplasma gallisepticum. Infect Immun (1993) 1.75
Thromboplastin related differences in the determination of international normalised ratio: a cause for concern? Steering Committee of the UK National External Quality Assessment Scheme in Blood Coagulation. Thromb Haemost (1994) 1.67
Lethal perinatal osteogenesis imperfecta due to the substitution of arginine for glycine at residue 391 of the alpha 1(I) chain of type I collagen. J Biol Chem (1987) 1.54
Molecular cloning and characterization of the novel, human complement-associated protein, SP-40,40: a link between the complement and reproductive systems. EMBO J (1989) 1.52
Lipoprotein (a), cholesterol and triglycerides in women with venous thromboembolism. Blood Coagul Fibrinolysis (2000) 1.50
Familial thrombophilia and lifetime risk of venous thrombosis. J Thromb Haemost (2004) 1.44
Injecting drug use is a risk factor for deep vein thrombosis in women in Glasgow. Br J Haematol (2001) 1.44
Low-molecular-weight heparin for immediate management of thromboembolic disease in pregnancy. Lancet (1998) 1.43
Educational outcomes of a workplace screening program for genetic susceptibility to hemochromatosis. Clin Genet (2006) 1.42
The organisation of the multigene family which encodes the major cell surface protein, pMGA, of Mycoplasma gallisepticum. FEBS Lett (1994) 1.41
Deletion of 24 amino acids from the pro-alpha 1(I) chain of type I procollagen in a patient with the Ehlers-Danlos syndrome type VII. J Biol Chem (1986) 1.41
Acquired activated protein-C resistance in pregnancy and association with increased thrombin generation and fetal weight. Lancet (1999) 1.40
Risk factors for pregnancy associated venous thromboembolism. Thromb Haemost (1997) 1.37
Partial primary structure of the T4 antigens of mouse and sheep: assignment of intrachain disulfide bonds. Proc Natl Acad Sci U S A (1986) 1.36
Expression studies on four members of the pMGA multigene family in Mycoplasma gallisepticum S6. Microbiology (1995) 1.36
Characterization of a major hemagglutinin protein from Mycoplasma gallisepticum. Infect Immun (1992) 1.35
Blood loss with knee joint replacement. J R Coll Surg Edinb (1981) 1.33
Expression of the pMGA genes of Mycoplasma gallisepticum is controlled by variation in the GAA trinucleotide repeat lengths within the 5' noncoding regions. Infect Immun (1998) 1.31
Prevalence of protein C deficiency in the healthy population. Thromb Haemost (1995) 1.28
Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Health Technol Assess (2006) 1.27
Mycoplasma synoviae has two distinct phase-variable major membrane antigens, one of which is a putative hemagglutinin. Infect Immun (1997) 1.26
Expression of two members of the pMGA gene family of Mycoplasma gallisepticum oscillates and is influenced by pMGA-specific antibodies. Infect Immun (1998) 1.25
A study of Protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state. Br J Haematol (2001) 1.22
Contact sensitivity to azobenzenearsonate and its inhibition after interaction of sensitized cells with antigen-conjugated cells. J Exp Med (1981) 1.22
SP-40,40 is an inhibitor of C5b-6-initiated haemolysis. Int Immunol (1989) 1.17
The murine Fc receptor for immunoglobulin: purification, partial amino acid sequence, and isolation of cDNA clones. Proc Natl Acad Sci U S A (1986) 1.17
Disordered "fibrinolytic potential" in coronary heart disease. Thromb Res (1977) 1.16
Prevalence of antithrombin deficiency in the healthy population. Br J Haematol (1994) 1.13
Human seminal clusterin (SP-40,40). Isolation and characterization. J Clin Invest (1990) 1.12
'Last-ditch' use of recombinant factor VIIa in patients with massive haemorrhage is ineffective. Vox Sang (2004) 1.08
Acylated streptokinase--plasminogen complex in patients with acute myocardial infarction. Thromb Haemost (1984) 1.08
Audit of oral anticoagulant treatment. The BCSH Haemostasis and Thrombosis Task Force of the British Society for Haematology. J Clin Pathol (1993) 1.06
Characterization of a 95,000 molecule on sheep leucocytes homologous to murine Pgp-1 and human CD44. Immunology (1988) 1.06
Freeze dried cryoprecipitate: a clinical evaluation. J Clin Pathol (1983) 1.04
Evaluation of an automated prothrombin assay using a chromogenic substrate. Haemostasis (1984) 1.04
pMGA phenotypic variation in Mycoplasma gallisepticum occurs in vivo and is mediated by trinucleotide repeat length variation. Infect Immun (2000) 1.03
Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost (1998) 1.03
The keratin chains of avian scale tissue. Sequence heterogeneity and the number of scale keratin genes. Eur J Biochem (1976) 1.02
Induction of delayed-type hypersensitivity to azobenzenearsonate by a monoclonal anti-idiotype antibody. J Exp Med (1981) 1.02
Immunoglobulin Cmu RNA in T lymphoma cells is not translated. Nature (1980) 0.98
The W and L allelic forms of phenylalanine hydroxylase in the rat differ by a threonine to isoleucine substitution. Biochem J (1986) 0.98
The immunoreactive 116 kDa surface protein of Mycoplasma pneumoniae is encoded in an operon. Microbiology (1997) 0.97
Allelic forms of beta 2-microglobulin in the mouse. Proc Natl Acad Sci U S A (1980) 0.96
Genetic susceptibility screening in schools: attitudes of the school community towards hereditary haemochromatosis. Clin Genet (2005) 0.96
Identification of Mycoplasma synoviae immunogenic surface proteins and their potential use as antigens in the enzyme-linked immunosorbent assay. Avian Dis (1996) 0.96
SP-40,40, a protein involved in the control of the complement pathway, possesses a unique array of disulphide bridges. FEBS Lett (1992) 0.96
Prevalence of the post-thrombotic syndrome in young women with previous venous thromboembolism. Br J Haematol (2000) 0.95
Comparison of thymic and peripheral T cell Ly-2/3 antigens. Eur J Immunol (1984) 0.95
Ly antigens associated with T cell recognition and effector function. Immunol Rev (1984) 0.94
The subunits of rabbit-muscle phosphofructokinase. A search for sequence repetition. Eur J Biochem (1976) 0.93
Mechanism of the resistance to cytotoxicity which precedes aflatoxin B1 hepatocarcinogenesis. Carcinogenesis (1981) 0.93
Several vascular complement inhibitors are present on human sperm. Biol Reprod (1993) 0.92
The amino-terminal sequences of Ly-2 and Ly-3. Immunogenetics (1986) 0.92
The secreted cathepsin L-like proteinases of the trematode, Fasciola hepatica, contain 3-hydroxyproline residues. Biochem J (1994) 0.92
Eosinophil interactions with Haemonchus contortus larvae in the ovine gastrointestinal tract. Parasite Immunol (2006) 0.92
Acquired transient protein C deficiency in neonatal cardiac failure. Arch Dis Child (1990) 0.91
Low molecular weight heparin for the treatment of venous thromboembolism in pregnancy: a case series. BJOG (2002) 0.90
A comparison of the effects of pretreatment with phenobarbitone and 3-methylcholanthrene on the metabolism of aflatoxin B1 by rat liver microsomes and isolated hepatocytes in vitro. Chem Biol Interact (1981) 0.89
Serum levels of müllerian inhibiting substance in boys from birth to 18 years, as determined by enzyme immunoassay. J Clin Endocrinol Metab (1990) 0.89
Abnormal coagulation and deep venous thrombosis in patients with advanced cancer. Clin Lab Haematol (1999) 0.89
Antenatal use of enoxaparin for prevention and treatment of thromboembolism in pregnancy. BJOG (2000) 0.88
The L3T4 antigen in mouse and the sheep equivalent are immunoglobulin-like. Immunogenetics (1986) 0.88
A search for messenger RNA molecules bearing immunoglobulin VH nucleotide sequences in T cells. J Exp Med (1982) 0.88
mu Polypeptide phenotypes of lymphoid and myeloid cell lines containing RNA transcripts of the immunoglobulin C mu gene. J Immunol (1981) 0.87
A novel multi-gene family of sheep gamma delta T cells. Immunology (1994) 0.87
First MTP joint arthrodesis for the treatment of hallux rigidus: results of 29 consecutive cases using the foot health status questionnaire validated measurement tool. Foot (Edinb) (2008) 0.86
Prostacyclin in cardiopulmonary bypass operations. J Thorac Cardiovasc Surg (1982) 0.86
Hereditary thrombophilia and fetal loss: a prospective follow-up study. J Thromb Haemost (2004) 0.86
Platelet function testing: practice among UK National External Quality Assessment Scheme for Blood Coagulation participants, 2006. J Clin Pathol (2008) 0.86
Influence of demographic factors on antithrombin III activity in a healthy population. Br J Haematol (1993) 0.86
Purification and biochemical characterisation of a novel breast carcinoma associated mucin-like glycoprotein defined by antibody 3E1.2. Br J Cancer (1989) 0.85
Drug Points: Apparent interaction between warfarin and levonorgestrel used for emergency contraception. BMJ (2000) 0.85
Thrombophilia and venous thromboembolism after total hip or knee replacement surgery: a systematic review. J Thromb Haemost (2005) 0.85
The alpha-chain of murine CD8 lacks an invariant Ig-like disulfide bond but contains a unique intrachain loop instead. J Immunol (1989) 0.85
The structure of the murine Fc receptor for IgG. Assignment of intrachain disulfide bonds, identification of N-linked glycosylation sites, and evidence for a fourth form of Fc receptor. J Immunol (1988) 0.85
Prothrombin 20210 G-->A, MTHFR C677T mutations in women with venous thromboembolism associated with pregnancy. BJOG (2000) 0.84
Low thrombosis rate seen in blood donors and their relatives with inherited deficiencies of antithrombin and protein C: correlation with type of defect, family history, and absence of the factor V Leiden mutation. Blood Coagul Fibrinolysis (1996) 0.84
A double blind study of prostacyclin in cardiopulmonary bypass surgery. Br J Haematol (1981) 0.84
"Fibrinolytic potential": the response to a 5 minute venous occlusion test. Thromb Res (1976) 0.84
Two-dimensional gel analysis demonstrates no structural alteration of HLA-B27 polypeptides between patients with ankylosing spondylitis and healthy individuals. Ann Rheum Dis (1984) 0.84
The apolipoprotein A-I binding protein of placenta and the SP-40,40 protein of human blood are different proteins which both bind to apolipoprotein A-I. Biochim Biophys Acta (1991) 0.83
Preferences for results from genomic microarrays: comparing parents and health care providers. Clin Genet (2014) 0.83
Combined prednisolone and intravenous immunoglobulin treatment for acquired factor VIII inhibitors: a 2-year review. Haemophilia (2001) 0.82
Characterisation of a novel Kunitz-type molecule from the trematode Fasciola hepatica. Mol Biochem Parasitol (1995) 0.82
Impact of a genetic diagnosis of a mitochondrial disorder 5-17 years after the death of an affected child. J Genet Couns (2008) 0.82
Interaction between hormone replacement therapy preparations and oral anticoagulant therapy. BJOG (2003) 0.82
Thrombocytopenia and leucopenia precipitated by pregnancy in a woman with myasthenia gravis. BJOG (2000) 0.82
Possible mechanism for differences in sensitivity to cis-platinum in human prostate tumor cell lines. Cancer Lett (1986) 0.82
Molecular characterization of the murine cytotoxic T-cell membrane glycoprotein Ly-3 (CD8). Proc Natl Acad Sci U S A (1987) 0.82
Testicular descent. II. Ontogeny and response to denervation of calcitonin gene-related peptide receptors in neonatal rat gubernaculum. Endocrinology (1993) 0.81
Lymph node homing cells biologically enriched for gamma delta T cells express multiple genes from the T19 repertoire. Int Immunol (1994) 0.81
Hemopexin is a developmentally regulated, acute-phase plasma protein in the chicken. J Biol Chem (1986) 0.81